Briefing Note: Contract amendment with GlaxoSmithKline Inc. for Sotrovimab for the treatment of COVID-19

Back to search
Title:
Contract amendment with GlaxoSmithKline Inc. for Sotrovimab for the treatment of COVID-19
Additional Information:
-
Received:
Dec 20, 2021
Organization:
Public Services and Procurement Canada
Sector:
Acquisitions Program
Addressee:
Minister
Action Required:
For Decision
Reference Number:
168834